About

Publications While At HealthPartners

selected publications

Journal Article

End-of-life measures in Huntington disease: HDQLIFE meaning and purpose, concern with death and dying, and end of life planning. 

Journal of Neurology. 2019

A new measure for end of life planning, preparation, and preferences in Huntington disease: HDQLIFE end of life planning. 

Journal of Neurology. 2018

Agreement between clinician-rated versus patient-reported outcomes in Huntington disease. 

Journal of Neurology. 2018

Relationships among apathy, health-related quality of life, and function in Huntington's disease. 

Journal of Neuropsychiatry and Clinical Neurosciences. 2018

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. 

Neurology. 2017

Clinical-genetic associations in the Prospective Huntington at Risk Observational Study (PHAROS): implications for clinical trials. 

JAMA neurology. 2016

HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD). 

Quality of Life Research. 2016

HDQLIFE: the development of two new computer adaptive tests for use in Huntington disease, speech difficulties, and swallowing difficulties. 

Quality of Life Research. 2016

New measures to capture end of life concerns in Huntington disease: Meaning and Purpose and Concern with Death and Dying from HDQLIFE (a patient-reported outcomes measurement system). 

Quality of Life Research. 2016

Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. 

Neurology. 2008

Replication of association between ELAVL4 and Parkinson disease: the GenePD study. 

Human Genetics. 2008

The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. 

BMC Medicine. 2008

Contact

full name

J. S. Perlmutter

Quick Info

 

Collaboration

Co-author network

Map of science